ACUTE LEUKEMIAS
Clinical trials for ACUTE LEUKEMIAS explained in plain language.
Never miss a new study
Get alerted when new ACUTE LEUKEMIAS trials appear
Sign up with your email to follow new studies for ACUTE LEUKEMIAS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New targeted drug hopes to tackle tough leukemia cases
Disease control Recruiting nowThis study tests a new drug, bleximenib, for people with acute leukemia that has come back or not responded to other treatments. The drug targets specific genetic changes in leukemia cells. The study has two phases: first to find the best dose and check safety, then to see how we…
Matched conditions: ACUTE LEUKEMIAS
Phase: PHASE1, PHASE2 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated May 26, 2026 09:56 UTC
-
Tracking a leukemia Drug's journey through the body
Knowledge-focused Recruiting nowThis study looks at how the body absorbs, breaks down, and gets rid of a radioactive form of the drug bleximenib in 10 people with acute leukemia. Participants have a type of leukemia that has come back or not responded to other treatments. The goal is to understand the drug's pa…
Matched conditions: ACUTE LEUKEMIAS
Phase: PHASE1 • Sponsor: Janssen Research & Development, LLC • Aim: Knowledge-focused
Last updated May 18, 2026 12:12 UTC